Sg Americas Securities, LLC Vor Biopharma Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$1.8 - $2.85 $14,605 - $23,124
-8,114 Reduced 38.1%
13,182 $31,000
Q4 2023

Jan 12, 2024
BUY
$1.66 - $2.63 $6,703 - $10,619
4,038 Added 23.4%
21,296 $48,000
Q3 2023

Oct 13, 2023
BUY
$2.1 - $3.35 $36,241 - $57,814
17,258 New
17,258 $37,000
Q4 2021

Feb 07, 2022
SELL
$11.32 - $18.02 $123,025 - $195,841
-10,868 Closed
0 $0
Q3 2021

Nov 01, 2021
BUY
$12.24 - $20.38 $133,024 - $221,489
10,868 New
10,868 $170,000

Others Institutions Holding VOR

# of Institutions
57
Shares Held
41.2M
Call Options Held
9.3K
Put Options Held
100
View Full List

About Vor Biopharma Inc.

VOR Quotes by TradingView
  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $33.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email